Volastra Therapeutics Announces New and Expanded Partnerships with AI and Precision-Medicine Leaders to Broaden Potential of KIF18A Inhibitors Across Cancer tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Insilico Joins Scramble to Treat Solid Tumors by Targeting KIF18A genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
Life sciences veteran’s experience leading R&D organizations and bringing more than 25 products to market will support Volastra’s growing pipeline of treatments targeting chromosomally unstable cancersNEW YORK (BUSINESS WIRE) Volastra Therapeutics, a clinical-stage cancer biotechnology company, today announced the.
A study led by researchers at Memorial Sloan Kettering Cancer Center (MSK) and Weill Cornell Medicine discovered a new relationship between cancer cells and the immune system, and shows how cancer can selfishly hijack a normally helpful immune pathway.